tiprankstipranks
Cytokinetics (CYTK)
NASDAQ:CYTK
US Market

Cytokinetics (CYTK) Income Statement

Compare
1,016 Followers

Cytokinetics Income Statement

Last quarter (Q3 2024), Cytokinetics's total revenue was $463.00K, an increase of 22.49% from the same quarter last year. In Q3, Cytokinetics's net income was $-160.54M. See Cytokinetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 7.53M$ 94.59M$ 70.43M$ 55.83M$ 26.87M
Gross Profit
$ -322.59M$ -146.22M$ -89.51M$ -41.12M$ -59.26M
Operating Expenses
$ 173.61M$ 177.98M$ 96.80M$ 52.82M$ 39.61M
Depreciation and Amortization
$ 11.89M$ 8.40M$ 9.64M$ 1.83M$ 1.29M
EBITDA
$ -456.68M$ -329.40M$ -176.34M$ -86.78M$ -93.04M
Operating Income
$ -496.20M$ -324.20M$ -186.31M$ -93.94M$ -98.87M
Other Income/Expenses
$ -30.04M$ -64.75M$ -29.00M$ -33.35M$ -22.82M
Pretax Income
$ -526.24M$ -388.95M$ -215.31M$ -127.29M$ -121.69M
Net Income
$ -526.24M$ -402.55M$ -242.37M$ -164.13M$ -149.05M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.45$ -4.48$ -3.15$ -2.54$ -2.59
Diluted EPS
$ -5.45$ -4.48$ -3.15$ -2.54$ -2.59
Weighted Average Shares Outstanding
96.52M 89.83M 76.89M 64.52M 57.58M
Weighted Average Shares Outstanding (Diluted)
96.52M 89.83M 76.89M 64.52M 57.58M
Currency in USD

Cytokinetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis